Voglibose 0.3 mg (Mouth Dissolving) is an oral antidiabetic medication primarily used to control postprandial blood sugar levels in patients with type 2 diabetes mellitus. It belongs to the class of alpha-glucosidase inhibitors, which work by delaying the digestion and absorption of carbohydrates in the intestine, thereby reducing the sudden rise in blood glucose after meals. The mouth-dissolving formulation allows easy administration without water, making it convenient for patients with swallowing difficulties. This formulation is particularly beneficial for elderly patients, travelers, and those requiring flexible dosing without compromising efficacy. Regular use, along with diet and exercise, helps maintain better glycemic control and reduces the risk of diabetes-related complications.
